Results 131 to 140 of about 45,519 (269)

Ethanol Infusion in the Vein of Marshall for Persistent Atrial Fibrillation Ablation: Evidence From Randomized Controlled Trials

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Pulmonary vein isolation (PVI) is the cornerstone of catheter ablation (CA) for atrial fibrillation (AF), yet outcomes remain suboptimal in persistent AF patients. Ethanol infusion in the vein of Marshal (VoM), an embryological remnant implicated in AF pathogenesis, may enhance ablation efficacy.
Carolina Saleiro   +9 more
wiley   +1 more source

Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome

open access: yes
Rheumatology &Autoimmunity, EarlyView.
Lilian Vasaitis   +5 more
wiley   +1 more source

Acute colchicine intoxication complicated with complete AV block

open access: yesThe Turkish Journal of Pediatrics, 2015
Colchicine, is an old and well-known drug, used for treatment of rheumatic diseases. Nausea, vomiting, abdominal pain, and diarrhea are the clinical symptoms of colchicine poisoning. Cardiotoxicity can lead to mortality.
İlker Ertuğrul   +7 more
doaj  

New insights into the putative XX/XY sex chromosomal system in blue‐eyed red‐fin pleco Hypostomus soniae (Siluriformes, Loricariidae)

open access: yesJournal of Fish Biology, EarlyView.
Abstract Blue‐eyed red‐fin pleco Hypostomus soniae (family Loricariidae) presented a putative sex system XX/XY in early stage. Aiming to explore the inter‐populational karyotypic variation and proposed emergence of the XX/XY system, we studied 13 H. soniae individuals (6 males, 7 females) from the Tapajós River.
Luan Aércio Melo Maciel   +6 more
wiley   +1 more source

Colchicine and pseudogout [PDF]

open access: yesArthritis & Rheumatism, 1982
TomáS González, Marian Gantes
openaire   +2 more sources

Colchicine and cardiovascular events: An updated meta‐analysis of published randomized controlled trials

open access: yesJournal of Internal Medicine, EarlyView.
Abstract Background Colchicine shows promise in reducing cardiovascular risk, but a recent study raised the question whether this is really the case. We conducted a meta‐analysis of randomized controlled trials (RCTs) to assess its impact on cardiovascular outcomes in secondary prevention.
Sining Xie   +4 more
wiley   +1 more source

Colchicine and the risk of major adverse cardiovascular events in patients with gout and Type 2 diabetes: A nationwide cohort study

open access: yesJournal of Internal Medicine, EarlyView.
Abstract Background Type 2 diabetes mellitus (T2DM) and gout are associated with an increased risk of cardiovascular events. Despite the approval for the secondary prevention of cardiovascular diseases by the United States Food and Drug Administration in 2023, evidence regarding the effectiveness of colchicine among T2DM population remains limited ...
Minjeong Jeon   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy